An interventional study of Oral glucose tolerance in Prediabetes, sponsored by Ramathibodi Hospital. Completed at 1 site in Thailand. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-10-10.
Sponsored by Ramathibodi Hospital · Not applicable, Interventional, and Diagnostic
Hypothesis
1,021 studies on the registry are indexed under Prediabetic State; 242 are open to participants now.
This study's enrollment of 51 is below the median of 66 across 861 interventional studies indexed under Prediabetic State.
Browse Prediabetic State studies →Ramathibodi Hospital is the lead sponsor of 63 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Prediabetes patients with normal sleep duration (7-8 hours/ night) as measured objectively
Other: Oral glucose tolerance
Prediabetes patients with short sleep duration (\<6 hours/night) as measured objectively
Other: Oral glucose tolerance
GLP-1 Levels in Response to Oral Glucose Tolerance Test
Prediabetes patients with and without short sleep will undergo an oral glucose tolerance test with measurement of GLP-1 levels
Time frame: 2 weeks
| Milestone | Normal Sleepers | Short Sleepers |
|---|---|---|
| Started | 24 | 27 |
| Completed | 24 | 27 |
| Not completed | 0 | 0 |
Prediabetes patients with and without short sleep will undergo an oral glucose tolerance test with measurement of GLP-1 levels
| pmol/l.h | Short Sleepers | Normal Sleepers |
|---|---|---|
| GLP-1 Levels in Response to Oral Glucose Tolerance Test | 16.66 (12.21 to 21.10) | 18.57 (13.42 to 39.15) |
Collected over 18 month. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Normal Sleeper | 0/24 (0%) | 0/24 (0%) | 0/24 (0%) |
| Short Sleeper | 0/27 (0%) | 0/27 (0%) | 0/27 (0%) |
| Age, Continuous(years) | Normal Sleeper | Short Sleeper | Total |
|---|---|---|---|
| Mean | 55.5 ± 9.8 | 55.8 ± 6.7 | 55.7 ± 8.2 |
| Sex: Female, Male(Participants) | Normal Sleeper | Short Sleeper | Total |
|---|---|---|---|
| Female | 19 | 20 | 39 |
| Male | 5 | 7 | 12 |
| Race/Ethnicity, Customized(Participants) | Normal Sleeper | Short Sleeper | Total |
|---|---|---|---|
| Thai | 24 | 27 | 51 |
| Region of Enrollment(Participants) | Normal Sleeper | Short Sleeper | Total |
|---|---|---|---|
| Thailand | 24 | 27 | 51 |
| BMI(kg/m^2) | Normal Sleeper | Short Sleeper | Total |
|---|---|---|---|
| Mean | 26.7 ± 3.2 | 26.8 ± 3.8 | 26.8 ± 3.5 |
Documents are hosted by the registry — open the source record to download them.
The record gives a start of Oct 2014, a primary completion of Mar 2017 and a completion of Mar 2017. It does not say whether these dates are actual or estimated.
Results were first posted in Aug 2017, 5 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ramathibodi Hospital